Generative Artificial Intelligence Intervention and Individual Psychological Counseling on Emotional Distress in Young Adults
The Intervention Effect of Generative Artificial Intelligence (Emohaa) and Individual Psychological Counseling on Emotional Distress in Young Adults: A Randomized Controlled Trial
1 other identifier
interventional
222
0 countries
N/A
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of an AI-based mental health chatbot, Emohaa, in reducing symptoms of depression, anxiety, insomnia, and academic burnout among young adults experiencing emotional distress. A total of 222 participants will be randomly assigned to one of three groups: (1) AI chatbot intervention, (2) traditional counseling, or (3) waitlist control. The study spans six time points from baseline through one-month follow-up. Primary and secondary outcomes will be measured via validated self-report questionnaires. The intervention is delivered entirely online through a WeChat-integrated platform, ensuring high accessibility and scalability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2025
CompletedStudy Start
First participant enrolled
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2025
CompletedMay 28, 2025
May 1, 2025
3 months
May 18, 2025
May 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depression
The Patient Health Questionnaire-9 (PHQ-9) was employed in this study to measure depressive symptoms. This scale consists of 9 items, each rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with scores of 0-4 indicating no depressive symptoms, 5-9 indicating mild symptoms, 10-14 indicating moderate symptoms, and 15 or above indicating severe depressive symptoms. Previous research has demonstrated good reliability and validity for the Chinese version of the PHQ-9.
From enrollment to the end of treatment at 10 weeks
Anxiety
The Generalized Anxiety Disorder-7 (GAD-7) was used to assess anxiety symptoms in this study. This scale consists of 7 items, each rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 21, with scores of 0-4 indicating no anxiety symptoms, 5-9 indicating mild symptoms, 10-14 indicating moderate symptoms, and 15 or above indicating severe anxiety symptoms. Prior studies have shown that the Chinese version of the GAD-7 has good reliability and validity.
From enrollment to the end of treatment at 10 weeks
Secondary Outcomes (1)
Loneliness
From enrollment to the end of treatment at 10 weeks
Other Outcomes (1)
Satisfaction with the GAI intervention
From first GAI intervention to the end of treatment at 10 weeks
Study Arms (3)
Generative Artificial Intelligence Intervention Group
EXPERIMENTALParticipants will interact weekly with Emohaa via a WeChat-integrated interface for 30-minute sessions over a 6-week period. The chatbot uses fine-tuned large language models to simulate emotionally supportive conversations and provide personalized, non-directive psychological support.
Individual Psychological Counseling Group
EXPERIMENTALParticipants will receive six weekly sessions (face-to-face or remote) with trained counselors using structured, supportive counseling protocols derived from cognitive-behavioral therapy (CBT).
Waiting List Group
NO INTERVENTIONParticipants will not receive any intervention during the study period but will be offered access to Emohaa after study completion.
Interventions
The intervention is delivered via a generative artificial intelligence platform called Emohaa. Participants will register and gain access to the platform prior to the start of the trial. Emohaa's responses are based on Hill's helping skills theory in psychology and are designed to simulate the basic communication strategies of a human counselor. The system demonstrates strong capabilities in active listening, emotional mirroring, and empathy, supporting users in understanding their own thoughts and feelings, learning to cope with emotional challenges, and achieving a more optimistic and positive mental and emotional state.
Participants in the traditional counseling group will receive individual psychological counseling sessions conducted by certified psychotherapists.
Eligibility Criteria
You may qualify if:
- Age ranges from 15 to 30
- Suffering from emotional distress (PHQ-9 \> 14 or GAD-7 \> 12)
- Ability to use the mobile phone to interact with AI
- Consent to participate in the study
You may not qualify if:
- High risk of self-injury and suicide
- Presence of psychotic symptoms (i.e., delusions)
- Serious substance use problems
- Other mental or physical illnesses requiring urgent medical assistance
- Received other psychological or pharmacological interventions in the last month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Central University of Finance and Economics, Chinalead
- Beijing Normal Universitycollaborator
- China Agricultural Universitycollaborator
- Qinghai Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zhihong Qiao, Doctor
Beijing Normal University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate researcher
Study Record Dates
First Submitted
May 18, 2025
First Posted
May 28, 2025
Study Start
May 20, 2025
Primary Completion
August 30, 2025
Study Completion
September 10, 2025
Last Updated
May 28, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
We will release the statistical analysis results based on the research design after anonymizing the personal identification information of the participants. And the raw data of each participant can be obtained through the corresponding author of the research report.